Play Video
1
Syncplicity Customer Success Story - Driving User Adoption at Acorda Therapeutics
Syncplicity Customer Success Story - Driving User Adoption at Acorda Therapeutics
::2014/10/06::
Play Video
2
Acorda Therapeutics CEO Ron Cohen, MD takes the ALS ice bucket challenge
Acorda Therapeutics CEO Ron Cohen, MD takes the ALS ice bucket challenge
::2014/08/15::
Play Video
3
Acorda Therapeutics Disaster Recovery Strategy with VMware SRM
Acorda Therapeutics Disaster Recovery Strategy with VMware SRM
::2012/11/05::
Play Video
4
Acorda Therapeutics 100% virtualized environment
Acorda Therapeutics 100% virtualized environment
::2012/11/05::
Play Video
5
Acorda Therapeutics on EMC VSPEX
Acorda Therapeutics on EMC VSPEX
::2013/09/09::
Play Video
6
Ron Cohen, President and CEO of Acorda Therapeutics, Inc.
Ron Cohen, President and CEO of Acorda Therapeutics, Inc.
::2012/02/16::
Play Video
7
News Update: Acorda Therapeutics (NASDAQ:ACOR) announce Ampyra Pricing
News Update: Acorda Therapeutics (NASDAQ:ACOR) announce Ampyra Pricing
::2010/02/08::
Play Video
8
Spotlight - Acorda Therapeutics - Bloomberg
Spotlight - Acorda Therapeutics - Bloomberg
::2009/07/01::
Play Video
9
Acorda Therapeutics, Inc. wins 2012 Gold Stevie Award
Acorda Therapeutics, Inc. wins 2012 Gold Stevie Award
::2012/09/27::
Play Video
10
Acorda Therapeutics
Acorda Therapeutics
::2013/03/17::
Play Video
11
Acorda Therapeutics, Inc - 2014 Small Business Award
Acorda Therapeutics, Inc - 2014 Small Business Award
::2014/04/29::
Play Video
12
Earnings Report: Acorda Therapeutics (NYSE:ACOR) Reports Inline Loss, Top Line Up 15.9%
Earnings Report: Acorda Therapeutics (NYSE:ACOR) Reports Inline Loss, Top Line Up 15.9%
::2010/02/23::
Play Video
13
Ron Cohen of Acorda Therapeutics wins a 2011 Stevie Award
Ron Cohen of Acorda Therapeutics wins a 2011 Stevie Award
::2011/06/27::
Play Video
14
Acorda Therapeutics Prints Unexpected Profit As Sales Jump 318%
Acorda Therapeutics Prints Unexpected Profit As Sales Jump 318%
::2010/11/01::
Play Video
15
Acorda Therapeutics Reported Mixed Q4 Results
Acorda Therapeutics Reported Mixed Q4 Results
::2011/02/17::
Play Video
16
Technical Analysis: After Yesterday
Technical Analysis: After Yesterday's Rally of 4.27%, Acorda Therapeutics Shares Could Pullback
::2010/05/13::
Play Video
17
"Bearish Moving Average Cross by Acorda Therapeutics "
"Bearish Moving Average Cross by Acorda Therapeutics "
::2011/02/04::
Play Video
18
Acorda Therapeutics wins the first of two 2011 Stevie Awards
Acorda Therapeutics wins the first of two 2011 Stevie Awards
::2011/06/30::
Play Video
19
Acorda Therapeutics (NASDAQ:ACOR) Stock Trading Idea: 15.6% Return in 3 Months
Acorda Therapeutics (NASDAQ:ACOR) Stock Trading Idea: 15.6% Return in 3 Months
::2010/01/25::
Play Video
20
Acorda Therapeutics Missed Q2 Estimates, Top Line Up Nearly 53% YoY
Acorda Therapeutics Missed Q2 Estimates, Top Line Up Nearly 53% YoY
::2011/08/01::
Play Video
21
Acorda Therapeutics Wins a Gold Stevie Award at The 2012 American Business Awards
Acorda Therapeutics Wins a Gold Stevie Award at The 2012 American Business Awards
::2012/06/27::
Play Video
22
Acorda Therapeutics Inc Stock Rises on Civitas Acquisition
Acorda Therapeutics Inc Stock Rises on Civitas Acquisition
::2014/09/25::
Play Video
23
Acorda Therapeutics   Pipeline and Label Expansion of AMPYRA  Drivers of Growth - Reports Corner
Acorda Therapeutics Pipeline and Label Expansion of AMPYRA Drivers of Growth - Reports Corner
::2013/07/17::
Play Video
24
Acorda Shares Drop on European Regulators
Acorda Shares Drop on European Regulators' Rejection of MS Drug
::2011/01/21::
Play Video
25
Acorda
Acorda's Cohen Sees Demand Growth for MS Drug Ampyra: Video
::2012/03/23::
Play Video
26
Acorda Shares Drop on European Regulators
Acorda Shares Drop on European Regulators' Rejection of MS Drug
::2011/01/21::
Play Video
27
Acorda Falls Back to Earth Following Monday Gains, Shares Slide 8%
Acorda Falls Back to Earth Following Monday Gains, Shares Slide 8%
::2011/01/12::
Play Video
28
rHigM22: A Novel Investigational Compound to Enhance Remyelination in the CNS
rHigM22: A Novel Investigational Compound to Enhance Remyelination in the CNS
::2013/12/20::
Play Video
29
Cohen Says Acorda Is Looking to Develop New Drugs
Cohen Says Acorda Is Looking to Develop New Drugs
::2011/06/27::
Play Video
30
Being Money Smart - Financial Wellness Webinar Series
Being Money Smart - Financial Wellness Webinar Series
::2012/09/06::
Play Video
31
Working2Walk2011, Anthony Caggiano
Working2Walk2011, Anthony Caggiano
::2012/09/02::
Play Video
32
Technical Analysis Review of the Stock Market 10/02/06
Technical Analysis Review of the Stock Market 10/02/06
::2006/10/02::
Play Video
33
SCI Hall of Fame 2007, Part 11
SCI Hall of Fame 2007, Part 11
::2007/11/30::
Play Video
34
Technical Analysis Review of the Stock Market 10/03/06
Technical Analysis Review of the Stock Market 10/03/06
::2006/10/03::
Play Video
35
World Satellite Television  News FAMPRIDINE SPINAL INJURY RX ELECTRONIC PRESS KIT
World Satellite Television News FAMPRIDINE SPINAL INJURY RX ELECTRONIC PRESS KIT
::2014/02/05::
Play Video
36
Chart of the Day  - ACOR, EXXI, MNTA, RXi - Harry Boxer, TheTechTrader.com
Chart of the Day - ACOR, EXXI, MNTA, RXi - Harry Boxer, TheTechTrader.com
::2010/02/01::
Play Video
37
Developing Cures, Creating Jobs in the Westchester/Hudson Valley Region
Developing Cures, Creating Jobs in the Westchester/Hudson Valley Region
::2012/10/16::
Play Video
38
Technical Analysis Review of the Stock Market 10/4/06
Technical Analysis Review of the Stock Market 10/4/06
::2006/10/04::
Play Video
39
The Multiple Sclerosis Therapy Market is on the Verge of an Overhaul
The Multiple Sclerosis Therapy Market is on the Verge of an Overhaul
::2012/06/19::
Play Video
40
Ron_Cohen-"I am Biotech" Series
Ron_Cohen-"I am Biotech" Series
::2012/11/03::
Play Video
41
Sarcastic - Glorious... Acorda
Sarcastic - Glorious... Acorda
::2011/04/28::
Play Video
42
TEDxRochester - Mark Noble - 11/7/11
TEDxRochester - Mark Noble - 11/7/11
::2012/04/02::
Play Video
43
2014 Annual MS Symposium
2014 Annual MS Symposium
::2014/10/16::
Play Video
44
Mãe acorda filho para não perde a hora da aula, Muleque surta!
Mãe acorda filho para não perde a hora da aula, Muleque surta!
::2013/08/14::
Play Video
45
2014 New York SmartCEO EMA Awards - CIO, CTO and COO
2014 New York SmartCEO EMA Awards - CIO, CTO and COO
::2014/04/30::
Play Video
46
Pre-Market Movers: January 21st, 2011
Pre-Market Movers: January 21st, 2011
::2011/01/21::
Play Video
47
2014 New York SmartCEO EMA Awards - CFO
2014 New York SmartCEO EMA Awards - CFO
::2014/04/30::
Play Video
48
2014 New York SmartCEO EMA Awards - CXO
2014 New York SmartCEO EMA Awards - CXO
::2014/04/30::
Play Video
49
Plenary - Who Will Pay for Tomorrow
Plenary - Who Will Pay for Tomorrow's Medical Breakthroughs?
::2011/11/08::
Play Video
50
Maria Flor acorda com cólica
Maria Flor acorda com cólica
::2014/03/06::
NEXT >>
RESULTS [51 .. 101]
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Acorda Therapeutics Inc.
Type Public
Traded as NASDAQACOR FWBCDG
Industry Health care
Biotechnology
Founded 1995 (1995)[1]
Founders Ron Cohen
Headquarters Ardsley, New York, United States
Key people Ron Cohen
Andrew R. Blight
Products Zanaflex
Ampyra
Qutenza
Revenue Increase US$292.2 Million (FY 2011)[2]
Operating income Increase US$35.1 Million (FY 2011)[2]
Net income Increase US$30.6 Million (FY 2011)[2]
Total assets Increase US$379.5 Million (FY 2011)[2]
Total equity Increase US$205.2 Million (FY 2011)[2]
Employees 328 (February, 2012) [2]
Website Acorda.com

Acorda Therapeutics is a biotechnology company based in Ardsley, New York, USA. The company develops drugs to improve therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system.[3] Acorda manufactures and markets the drugs Zanaflex, Ampyra and Qutenza in the United States.

History[edit]

Corporate governance[edit]

As of December 31, 2013, the members of the board of directors of Acorda Therapeutics were:[4] Ron Cohen, Barry Greene, Peder K. Jensen, John P. Kelley, Sandra Panem, Lorin J. Randall, Steven M. Rauscher, and Ian F. Smith.

Products[edit]

Products on the market[edit]

Products under development[edit]

References[edit]

External links[edit]


Wikipedia content is licensed under the GFDL License
Powered by YouTube
LEGAL
  • Mashpedia © 2014